Skip to main content

Find Clinical Trials

Home
Conditions
Filoviridae Infections

Clinical trial condition

Filoviridae Infections

Explore clinical trials studying Filoviridae Infections. Study availability and eligibility vary by location and protocol.

82 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Filoviridae Infections trial results

Completed

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

NCT02818582

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Partnership of Clinical Research in Guinea (PREGUI) / Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah Forécariah, Maferinyah, Guinea

JFK Hospital Partnership for Research for Vaccines and Infectious Diseases in Liberia (PREVAIL) Monrovia, Liberia

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

NCT02370589

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Q-Pharm Pty Ltd. Brisbane, Queensland, Australia

Nucleus Network Melbourne, Victoria, Australia

Linear Clinical Research Nedlands, Western Australia, Australia

View Trial Details

Completed

Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy

NCT04385719

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +19 more
Locations: Infectious Diseases Institute Kampala, Uganda

View Trial Details

Completed

A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430

NCT03800173

Conditions: Animal Diseases, Filoviridae Infections, Hemorrhagic Fevers, Viral, +7 more
Locations: PRA Health Sciences Lenexa, Kansas, United States

View Trial Details

Completed

ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)

NCT04028349

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: MRC/UVRI & LSHTM Uganda Research Unit Entebbe, Uganda

View Trial Details

Completed

Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease

NCT04815174

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: BENI ETC Beni, North Kivu, Democratic Republic of the Congo

View Trial Details

Completed

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults

NCT03478891

Conditions: Filoviridae Infections, Healthy Adult Immune Responses to Vaccine, Hemorrhagic Fever, Ebola, +5 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

NCT03072030

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +6 more
Locations: Centre de recherche en épidémiologie, microbiologie et de soins médicaux (CREMS) de Pastoria à Kindia Kindia, Guinea

Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department Moscow, Russia

View Trial Details

Completed

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

NCT03140774

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: MRC - University of Glasgow Centre for Virus Research Glasgow, United Kingdom

Oxford Vaccine Group, University of Oxford Oxford, United Kingdom

View Trial Details

Completed

Experimental Ebola Vaccine Trial

NCT00072605

Conditions: Filoviridae Infections, Healthy, Hemorrhagic Fever, Ebola, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details